A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial

Peer Review reports

Original Submission
28 Oct 2015	Submitted	Original manuscript
19 Jan 2016	Reviewed	Reviewer Report - Catherine D'Este
26 Apr 2016	Reviewed	Reviewer Report - Everardo Saad
26 May 2016	Author responded	Author comments - Annika Karch
Resubmission - Version 2
26 May 2016	Submitted	Manuscript version 2
2 Jun 2016	Reviewed	Reviewer Report - Catherine D'Este
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
7 Jun 2016	Editorially accepted
7 Jul 2016	Article published	10.1186/s13063-016-1434-x

Back to article page